Agomab Therapeutics NV — SCHEDULE 13D Filings

1 SCHEDULE 13D filing on record

This page lists all SCHEDULE 13D filings submitted to the SEC by Agomab Therapeutics NV (AGMB), sorted by most recent first. Each row links to the full filing on EdgarLookup. Agomab Therapeutics NV has filed 1 SCHEDULE 13D document with the SEC since 2024. To view all SEC filings by Agomab Therapeutics NV, see the full filings list.

Overview All Filings Financials Insiders

All 3 424B4 6-K 8-A12B CERT DRS DRS/A EFFECT F-1 F-1/A S-8 SCHEDULE 13D SCHEDULE 13G

Form	Description	Accession Number	Filed	Period
SCHEDULE 13D	—	0001193125-26-052946	Feb 17, 2026	—